FibroTest/FibroSure Scientific Publications

1041 HCV Multicentric US trials using FibroTest to diagnose cirrhosis in HCV Twelve weeks of sofosbuvir plus ribavirin is effective for treatment of genotype 2 HCV in difficult to treat u.s. veterans with cirrhosis – Results of the VALORHCV study. Samuel B. Ho1, Monto A, et al. FibroTest is used to identify cirrhotic in an open-label study to evaluate the safety and efficacy of 12 weeks of SOF+RBV in genotype-2 HCV infected veterans. The study was conducted at 15 U.S. VA sites: 15% of subjects were African American, 9% Hispanic, among them with vascular (71.2%) or metabolic (62.1%) comorbidities. ✓ Cirrhosis was diagnosed by FibroTest (58%), FibroScan (26%), biopsy (12%), and imaging (5%). VALORHCV is the largest prospective study of SOF+RBV in GT2 cirrhotic and confirms the effectiveness of all-oral SOF+RBV for 12 weeks in this difficult to treat population.